Psychotropic medication during endocrine treatment for breast cancer

Bock, Geertruida H. de; Musters, Regina F.; Bos, H. J. T.; Schroder, C.; Mourits, Marian J.E.; Berg, Lolkje Theodora Wilhelmina de Jong-van den

doi:10.1007/s00520-011-1242-5

Cited by 23 publications

(20 citation statements)

References 19 publications

(23 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We also found that patients in both groups experienced many physical symptoms after surgery that were not observed after diagnosis. Their side effects were debilitating: chemotherapy can lead to nausea, constipation, deformed nails and hair loss (6,7); radiotherapy may cause skin changes and itchiness (8,9); and endocrine treatment can trigger hot flashes and headaches (10,11). Our results, in which patients also experienced side effects after surgery, support these reports.…”

Section: Discussionsupporting

confidence: 81%

The Relationship Between Emotional Suppression and Psychological Distress in Breast Cancer Patients After Surgery

Nakatani

Iwamitsu

Kuranami

et al. 2014

Japanese Journal of Clinical Oncology

View full text Add to dashboard Cite

Objective: The purpose of this study was to examine the relationship between emotional suppression and psychological distress in breast cancer patients after surgery. We examined this relationship using questionnaires at the first visit to the breast cancer outpatient clinic at our hospital and after surgery, as well as interviews after surgery. Methods: A total of 31 breast cancer patients were asked to complete the Courtauld Emotional Control Scale and the Profile of Mood States at their first visit to the outpatient clinic. Patients were also asked to complete the Profile of Mood States between 1 and 6 months after surgery. Trained clinical psychologists conducted the interviews, asking patients to speak freely about their current anxieties, worries and thoughts. Based on the median Courtauld Emotional Control Scale score of 42 points, participants were divided into emotional suppression and emotional expression groups. Results: The Total Mood Disturbance score, as well as each of the subscale (except vigor) scores of the Profile of Mood States, were significantly higher in the emotional suppression group than the emotional expression group. The emotional suppression group expressed significantly more negative emotions and fewer positive emotions than the emotional expression group. Conclusions: Patients with emotional suppression felt and expressed more psychological distress after surgery. This finding highlights the need for medical staff to comprehend the psychological traits of breast cancer patients, including emotional suppression, in the early stages of breast cancer in order to provide adequate psychological support.

show abstract

Section: Discussionsupporting

confidence: 81%

The Relationship Between Emotional Suppression and Psychological Distress in Breast Cancer Patients After Surgery

Nakatani

Iwamitsu

Kuranami

et al. 2014

Japanese Journal of Clinical Oncology

View full text Add to dashboard Cite

show abstract

“…Other studies have reported on the long-term psychological impact of breast cancer and its treatment [29,30]. Recently, an increased prescription of psychotropic medication was found in breast cancer patients on endocrine therapy [23]. In our study, no significant differences between patients and reference population were observed for frequencies of women with any referral to mental healthcare.…”

Section: Discussioncontrasting

confidence: 41%

“…Primary healthcare use in the first 5 years of the followup period was assessed by calculating frequencies of women with at least one annual face-to-face contact, drug prescription, and referral in this period. Based on the results of a previous study [23], primary healthcare use for psychological reasons and endocrine therapy-related reasons was also assessed. Due to small numbers, ICPC chapters and ATC chapters were analysed instead of subgroups.…”

Section: Discussionmentioning

confidence: 99%

Increased primary healthcare utilisation among women with a history of breast cancer

Roorda

Berendsen

Groenhof

et al. 2012

Support Care Cancer

Self Cite

View full text Add to dashboard Cite

Increased primary healthcare utilisation among women with a history of breast cancer Roorda, Carriene; Berendsen, Annette J.; Groenhof, Feikje; van der Meer, Klaas; de Bock, Geertruida H. Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum. Abstract Purpose Little is known about the current role of the general practitioner (GP) in breast cancer follow-up care. This study explores primary healthcare use in the period after completion of primary breast cancer treatment. Methods A total of 336 women with a history of early-stage breast cancer treated with curative intent were identified in the primary care database of the Registration Network Groningen (RNG) (1998)(1999)(2000)(2001)(2002)(2003)(2004)(2005)(2006)(2007) and matched with a reference population of 983 women without breast cancer on birth year and GP. Results Over the entire follow-up period (starting 1 year post-diagnosis), the median numbers of face-to-face contacts, drug prescriptions, and referrals in the patient group were significantly higher than those in the reference group: 4.0 vs. 3.2/year, 12.3 vs. 8.4/year, and 0.4 vs. 0.3/year, Mann-Whitney (M-W) test p<0.001 for all differences. At least one annual face-to-face contact was observed for 96.7 % of patients and 92.9 % of women from the reference population (Chi-square test p00.011). More patients than women from the reference population had face-to-face contacts for reasons related to breast cancer or were prescribed hormone antagonists and aromatase inhibitors to treat breast cancer. The main predictor of higher rates of face-to-face contacts and drug prescriptions was a higher age at diagnosis. ConclusionsThis study shows increased primary healthcare utilisation among women with a history of breast cancer, especially among the elderly. When follow-up is transferred to the primary care setting, new responsibilities of GPs might be incorporated into existing primary healthcare delivery.

show abstract

“…Nine articles detailed the full range of antidepressants. [28,33,37,47,48,52,56,61,62] In some instances, cancer patients received more than one type of antidepressant, [37,49,52] or the type of antidepressant changed over the course of cancer treatment [56].…”

Section: Association Of Antidepressant Prescribing With Subgroup Charmentioning

confidence: 99%

A systematic review and meta‐analysis of prescribing practices of antidepressants in cancer patients

et al. 2016

View full text Add to dashboard Cite

Background: Antidepressants are commonly used for the pharmacological treatment of depression. We aimed to summarise the prevalence of antidepressant prescription to cancer patients, and differences by study or patient characteristics.Methods: PubMed, Embase, Web of Science, Scopus and psychINFO were searched using keywords 'psychotropic', 'antidepressants', 'prescription' and 'cancer'. Prevalence of antidepressants, type, dose and follow-up of antidepressants and prescriber details were extracted.Results: Overall, 1537 articles between 1979 and February 2015 were found, 38 met the inclusion criteria and were reviewed according to PRISMA guidelines. The prevalence rate of prescribing antidepressants to cancer patients was 15.6% (95% CI = 13.3-18.3). Prescription was significantly less common in studies from Asia (7.4%; 95% CI = 4.3-12.5), more common in female (22.6%; 95% CI = 16.0-31.0) or breast cancer patients (22.6%; 95% CI = 16.0-30.9). Selective serotonin reuptake inhibitors were the most frequently prescribed antidepressants. General practitioners and psychiatrists, followed by oncologists, were identified as the major providers of antidepressant prescriptions to cancer patients. Few studies reported the exact dose, length of time drugs were prescribed for or follow-up regimens.Conclusions: There is considerable variation in the prescribing patterns of antidepressants across the world, with few studies reporting robust data on exact dose or follow-up regimens. Prospective studies that monitor antidepressant prescribing, including details of reasons for prescribing and the healthcare providers involved, dose, change in dose or type of medication and follow-up are needed to ascertain whether patients are being treated optimally and if side effects or drug-drug interactions are identified and managed.

show abstract

Psychotropic medication during endocrine treatment for breast cancer

Cited by 23 publications

References 19 publications

The Relationship Between Emotional Suppression and Psychological Distress in Breast Cancer Patients After Surgery

The Relationship Between Emotional Suppression and Psychological Distress in Breast Cancer Patients After Surgery

Increased primary healthcare utilisation among women with a history of breast cancer

A systematic review and meta‐analysis of prescribing practices of antidepressants in cancer patients

Contact Info

Product

Resources

About